ctrl K

Price Alert

Angion Biomedica Corp. (ANGN)

NASDAQ: ANGN · Real-Time Price · USD

1.00

0.00 (0.00%)

At close: Jun 01, 2023, 10:00 PM

Angion Biomedica Revenue Breakdown

Period Ending	Dec 31, 2022	Dec 31, 2021
License Revenue	2.3M	15M
License Revenue Growth	-84.67%	n/a

Operating Expense Breakdown

Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019
Selling, General, and Administrative Revenue	2.96M	709K	3.14M	2.74M	3.51M	2.83M	4.28M	3.75M	3.31M	3.62M	4.47M	4.21M	3.93M	4.34M	6.01M	3.12M	5.98M	5.43M	3.46M	4.14M
Selling, General, and Administrative Revenue Growth	+317.21%	-77.39%	+14.29%	-21.76%	+23.79%	-33.82%	+14.31%	+12.97%	-8.30%	-19.06%	+6.18%	+7.02%	-9.45%	-27.81%	+92.82%	-47.84%	+9.99%	+57.31%	-16.61%	n/a
Research and Development Revenue	7.78M	21.12M	7.21M	8.18M	7.26M	4.94M	326K	160K	2.94M	6.07M	11.67M	6.67M	13.29M	14.44M	14.3M	11.06M	6.09M	12.23M	9.6M	10.45M
Research and Development Revenue Growth	-63.18%	+193.04%	-11.88%	+12.61%	+46.93%	+1416.56%	+103.75%	-94.55%	-51.62%	-47.95%	+74.97%	-49.82%	-8.00%	+1.02%	+29.22%	+81.81%	-50.24%	+27.45%	-8.15%	n/a